Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04070768
Title Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Big Ten Cancer Research Consortium
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Univeristy of Illinois Chicago Illinois 60612 United States Details
Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis Indiana 46202 United States Details
University of Michigan Health System Ann Arbor Michigan 48109 United States Details
University of Nebraska Medical Center Omaha Nebraska 68198 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field